キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/10/08 | 3,710 | 3,765 | 3,680 | 3,700 | -80 | -2.1% | 65,100 |
2024/10/07 | 3,700 | 3,785 | 3,660 | 3,780 | +80 | +2.2% | 107,300 |
2024/10/04 | 3,640 | 3,735 | 3,640 | 3,700 | +45 | +1.2% | 81,900 |
2024/10/03 | 3,630 | 3,670 | 3,585 | 3,655 | +95 | +2.7% | 123,000 |
2024/10/02 | 3,610 | 3,625 | 3,550 | 3,560 | -50 | -1.4% | 60,700 |
2024/10/01 | 3,545 | 3,615 | 3,540 | 3,610 | +65 | +1.8% | 52,500 |
2024/09/30 | 3,510 | 3,570 | 3,485 | 3,545 | -25 | -0.7% | 76,100 |
2024/09/27 | 3,540 | 3,610 | 3,525 | 3,570 | -45 | -1.2% | 97,700 |
2024/09/26 | 3,560 | 3,620 | 3,560 | 3,615 | +80 | +2.3% | 102,100 |
2024/09/25 | 3,535 | 3,555 | 3,500 | 3,535 | ±0 | ±0% | 52,400 |
2024/09/24 | 3,515 | 3,545 | 3,470 | 3,535 | +45 | +1.3% | 54,300 |
2024/09/20 | 3,535 | 3,565 | 3,465 | 3,490 | -5 | -0.1% | 105,200 |
2024/09/19 | 3,505 | 3,550 | 3,495 | 3,495 | +5 | +0.1% | 52,700 |
2024/09/18 | 3,510 | 3,520 | 3,460 | 3,490 | +50 | +1.5% | 77,600 |
2024/09/17 | 3,540 | 3,540 | 3,400 | 3,440 | -35 | -1% | 80,900 |
2024/09/13 | 3,455 | 3,475 | 3,440 | 3,475 | -5 | -0.1% | 52,800 |
2024/09/12 | 3,515 | 3,555 | 3,450 | 3,480 | +35 | +1% | 61,800 |
2024/09/11 | 3,540 | 3,565 | 3,420 | 3,445 | -110 | -3.1% | 69,500 |
2024/09/10 | 3,545 | 3,575 | 3,510 | 3,555 | +15 | +0.4% | 34,400 |
2024/09/09 | 3,510 | 3,580 | 3,450 | 3,540 | +10 | +0.3% | 80,700 |
2024/09/06 | 3,580 | 3,580 | 3,520 | 3,530 | -25 | -0.7% | 26,700 |
2024/09/05 | 3,550 | 3,580 | 3,535 | 3,555 | +5 | +0.1% | 42,200 |
2024/09/04 | 3,535 | 3,550 | 3,465 | 3,550 | -5 | -0.1% | 90,700 |
2024/09/03 | 3,495 | 3,570 | 3,490 | 3,555 | +85 | +2.4% | 56,900 |
2024/09/02 | 3,490 | 3,540 | 3,470 | 3,470 | +10 | +0.3% | 52,800 |
2024/08/30 | 3,470 | 3,505 | 3,460 | 3,460 | -20 | -0.6% | 103,700 |
2024/08/29 | 3,465 | 3,510 | 3,460 | 3,480 | -30 | -0.9% | 30,300 |
2024/08/28 | 3,490 | 3,510 | 3,460 | 3,510 | +10 | +0.3% | 69,700 |
2024/08/27 | 3,455 | 3,510 | 3,455 | 3,500 | +55 | +1.6% | 47,400 |
2024/08/26 | 3,500 | 3,500 | 3,405 | 3,445 | -100 | -2.8% | 80,400 |
2024/08/23 | 3,540 | 3,590 | 3,530 | 3,545 | +30 | +0.9% | 76,900 |
2024/08/22 | 3,520 | 3,525 | 3,480 | 3,515 | -5 | -0.1% | 50,600 |
2024/08/21 | 3,505 | 3,560 | 3,495 | 3,520 | +10 | +0.3% | 86,800 |
2024/08/20 | 3,515 | 3,520 | 3,485 | 3,510 | +20 | +0.6% | 58,600 |
2024/08/19 | 3,500 | 3,510 | 3,470 | 3,490 | -30 | -0.9% | 40,000 |
2024/08/16 | 3,540 | 3,540 | 3,485 | 3,520 | +20 | +0.6% | 50,400 |
2024/08/15 | 3,520 | 3,520 | 3,480 | 3,500 | ±0 | ±0% | 35,900 |
2024/08/14 | 3,510 | 3,520 | 3,465 | 3,500 | -10 | -0.3% | 37,500 |
2024/08/13 | 3,450 | 3,515 | 3,445 | 3,510 | +40 | +1.2% | 42,700 |
2024/08/09 | 3,545 | 3,545 | 3,415 | 3,470 | ±0 | ±0% | 108,800 |
2024/08/08 | 3,395 | 3,495 | 3,395 | 3,470 | +70 | +2.1% | 118,200 |
2024/08/07 | 3,300 | 3,490 | 3,250 | 3,400 | +30 | +0.9% | 109,500 |
2024/08/06 | 3,360 | 3,455 | 3,300 | 3,370 | +150 | +4.7% | 125,400 |
2024/08/05 | 3,200 | 3,345 | 3,150 | 3,220 | -110 | -3.3% | 233,100 |
2024/08/02 | 3,420 | 3,420 | 3,265 | 3,330 | -160 | -4.6% | 118,000 |
2024/08/01 | 3,445 | 3,515 | 3,415 | 3,490 | -5 | -0.1% | 135,200 |
2024/07/31 | 3,400 | 3,500 | 3,400 | 3,495 | +205 | +6.2% | 182,000 |
2024/07/30 | 3,300 | 3,310 | 3,265 | 3,290 | -10 | -0.3% | 53,300 |
2024/07/29 | 3,260 | 3,330 | 3,260 | 3,300 | +50 | +1.5% | 47,900 |
2024/07/26 | 3,270 | 3,275 | 3,240 | 3,250 | -5 | -0.2% | 32,600 |
151~
200
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サワイGHD | 188,900円 | +5.9% | +24.5% | 2.91% | 12.53倍 | 1.18倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム